Safety Alerts & Recalls
Hospira announced a voluntary recall of one lot of 0.9% Sodium Chloride Injection due to particulate matter sealed in the bag at the additive port area. The particulate matter was identified as a human hair.
The Food and Drug Administration (FDA) is warning healthcare professionals and consumers that counterfeit versions of Cialis (tadalafil; Eli Lilly) 20mg tablets were discovered in the mail in transit to a U.S. consumer.
The Food and Drug Administration (FDA) is advising consumers to not buy or use Happy Passengers, a product promoted and sold for sexual enhancement.
The Food and Drug Administration (FDA) is recommending against the routine use of bone graft substitutes containing recombinant proteins or synthetic peptides in patients under 18 years old.
The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are continuing to investigate multiple instances of Wallcur simulated intravenous (IV) saline products being administered to patients. These products are not sterile and are intended for training purposes only.
The Food and Drug Administration (FDA) has issued a statement regarding the benefits and potential risks associated with the use of prescription and over-the-counter (OTC) pain medications during pregnancy in response to recent reports questioning their safety when used during pregnancy.
Valeant announced a voluntary recall of one lot of Virazole (ribavirin powder for solution) due to microbial contamination.
Hospira announced a voluntary recall of 10 lots of Mitoxantrone after confirmation of subpotency and elevated impurity levels.
The Food and Drug Administration (FDA) is warning consumers to not buy or use Slim-K, a product marketed for weight loss.
Bethel Nutritional Consulting announced a voluntary recall of B-Lipo Capsules, an herbal supplement marketed for weight loss.